Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021

SELL
$61.91 - $67.42 $12.4 Million - $13.5 Million
-200,000 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $25.2 Million - $28.4 Million
-425,000 Reduced 68.0%
200,000 $12.6 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $36.1 Million - $40.9 Million
625,000 New
625,000 $38.8 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $40.2 Million - $44.5 Million
-700,000 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $4.39 Million - $5.13 Million
-80,000 Reduced 10.26%
700,000 $41.2 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $6.26 Million - $9.1 Million
-135,000 Reduced 14.75%
780,000 $43.5 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $9.59 Million - $12.5 Million
-194,900 Reduced 17.56%
915,000 $58.7 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $7.7 Million - $9.13 Million
180,000 Added 19.36%
1,109,900 $56.3 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $2.23 Million - $2.47 Million
50,000 Added 5.68%
929,900 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $11.3 Million - $13.4 Million
249,900 Added 39.67%
879,900 $42 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $4.39 Million - $5.69 Million
90,000 Added 16.67%
630,000 $32.7 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $29.8 Million - $33.6 Million
540,000 New
540,000 $33.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.